Literature DB >> 30428294

Clinical Course and Management of Hypertrophic Cardiomyopathy.

Barry J Maron1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30428294     DOI： 10.1056/NEJMc1812159

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

1.  Transcriptomic Analysis of Cardiomyocyte Extracellular Vesicles in Hypertrophic Cardiomyopathy Reveals Differential snoRNA Cargo.

Authors:  Victoria James; Zubair A Nizamudeen; Daniel Lea; Tania Dottorini; Terri L Holmes; Benjamin B Johnson; Kenton P Arkill; Chris Denning; James G W Smith
Journal:  Stem Cells Dev       Date:  2021-12-15       Impact factor: 3.272

Review 2.  Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside.

Authors:  Chiara Palandri; Lorenzo Santini; Alessia Argirò; Francesca Margara; Ruben Doste; Alfonso Bueno-Orovio; Iacopo Olivotto; Raffaele Coppini
Journal:  Drugs       Date:  2022-06-13       Impact factor: 11.431

Review 3.  Multiscale simulations of left ventricular growth and remodeling.

Authors:  Hossein Sharifi; Charles K Mann; Alexus L Rockward; Mohammad Mehri; Joy Mojumder; Lik-Chuan Lee; Kenneth S Campbell; Jonathan F Wenk
Journal:  Biophys Rev       Date:  2021-08-25

Review 4.  MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers.

Authors:  Fanyan Luo; Wei Liu; Haisong Bu
Journal:  Heart Fail Rev       Date:  2022-03-25       Impact factor: 4.654

5.  Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy.

Authors:  Maria Tafelmeier; Andrea Baessler; Stefan Wagner; Bernhard Unsoeld; Andrej Preveden; Fausto Barlocco; Alessia Tomberli; Dejana Popovic; Paul Brennan; Guy A MacGowan; Arsen Ristic; Lazar Velicki; Iacopo Olivotto; Djordje G Jakovljevic; Lars S Maier
Journal:  Clin Cardiol       Date:  2020-03-03       Impact factor: 2.882

6.  Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.

Authors:  Lazar Velicki; Djordje G Jakovljevic; Andrej Preveden; Miodrag Golubovic; Marija Bjelobrk; Aleksandra Ilic; Snezana Stojsic; Fausto Barlocco; Maria Tafelmeier; Nduka Okwose; Milorad Tesic; Paul Brennan; Dejana Popovic; Arsen Ristic; Guy A MacGowan; Nenad Filipovic; Lars S Maier; Iacopo Olivotto
Journal:  BMC Cardiovasc Disord       Date:  2020-12-09       Impact factor: 2.298

7.  Indications for Surgery in Obstructive Hypertrophic Cardiomyopathy.

Authors:  Mark V Sherrid
Journal:  J Am Heart Assoc       Date:  2020-12-21       Impact factor: 5.501

8.  Prevalence, functional characteristics, and clinical significance of right ventricular involvement in patients with hypertrophic cardiomyopathy.

Authors:  Jiwon Seo; Yoo Jin Hong; Young Jin Kim; Purevjargal Lkhagvasuren; Iksung Cho; Chi Young Shim; Jong-Won Ha; Geu-Ru Hong
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

9.  Patients who do not fulfill criteria for hypertrophic cardiomyopathy but have unexplained giant T-wave inversion: a cardiovascular magnetic resonance mid-term follow-up study.

Authors:  Shuang Li; Jian He; Jing Xu; Baiyan Zhuang; Bailing Wu; Bingqi Wei; Jinghan Huang; Gang Yin; Xiuyu Chen; Zhenhui Zhu; Hao Wang; Shihua Zhao; Minjie Lu
Journal:  J Cardiovasc Magn Reson       Date:  2021-06-03       Impact factor: 5.364

10.  Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis.

Authors:  Zetao Ma; Xizhi Wang; Qingbo Lv; Yingchao Gong; Minghong Xia; Lenan Zhuang; Xue Lu; Ying Yang; Wenbin Zhang; Guosheng Fu; Yang Ye; Dongwu Lai
Journal:  Pharmgenomics Pers Med       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.